These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Saiz A; Graus F; Dalmau J; Pifarré A; Marin C; Tolosa E Ann Neurol; 1999 Nov; 46(5):774-7. PubMed ID: 10970247 [TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment. Bataller L; Dalmau JO Semin Neurol; 2004 Dec; 24(4):461-71. PubMed ID: 15637657 [TBL] [Abstract][Full Text] [Related]
13. The clinical spectrum and pathogenesis of paraneoplastic disorders of the central nervous system. Rosenfeld MR; Dalmau J Hematol Oncol Clin North Am; 2001 Dec; 15(6):1109-28, vii. PubMed ID: 11770301 [TBL] [Abstract][Full Text] [Related]
14. Immune-mediated encephalopathies with an emphasis on paraneoplastic encephalopathies. Pruitt AA Semin Neurol; 2011 Apr; 31(2):158-68. PubMed ID: 21590621 [TBL] [Abstract][Full Text] [Related]
15. [Mental disorders in paraneoplastic syndromes]. Stepień A; Góral M; Kantorska-Janiec M Przegl Lek; 2008; 65(5):256-8. PubMed ID: 18853654 [TBL] [Abstract][Full Text] [Related]